Health Technology
Argentine companies engaged in health technology sector
These Argentine companies operate in the same sector, health technology. Each includes key stats like stock price, daily change, and trading volume to help you make more informed trading decisions. Whether you're tracking industry giants such as ELI LILLY AND COMPANY CEDEAR EACH 4 REPR 1 ORD NPV (USD) or looking at high-volume movers like INSTITUTO ROSENBUCH SA DE BIOLOGIA, this list offers valuable insights for any trading strategy. Filter and compare companies and stay on top of market trends easily.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)DR | 968.75 T ARS | 14.35 USD | +1.06% | 325 | 0.80 | 73.10 | 210.62 ARS | +167.86% | 0.42% | — |
| LLYCELI LILLY AND COMPANY CEDEAR EACH 4 REPR 1 ORD NPV (USD) DR | 968.75 T ARS | 14.15 USD | +2.54% | 15 | — | 72.08 | 210.62 ARS | +167.86% | 0.42% | — |
| LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 968.75 T ARS | 18,525 ARS | +2.63% | 6.49 K | 0.95 | 87.95 | 210.62 ARS | +235.69% | 0.42% | — |
 JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)DR | 482.51 T ARS | 10.30 USD | −2.83% | 1.56 K | 1.46 | 18.50 | 597.27 ARS | +144.56% | 1.67% | — |
| JNJCJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 482.51 T ARS | 10.30 USD | −1.44% | 2 | 0.01 | 18.50 | 597.27 ARS | +144.56% | 1.67% | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 482.51 T ARS | 13,550 ARS | +1.88% | 11 K | 1.09 | 22.69 | 597.27 ARS | +206.49% | 1.67% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 482.51 T ARS | 1,300 ARS | 0.00% | 1 | 0.10 | — | — | — | — | — |
 ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)DR | 432.61 T ARS | 19.35 USD | −0.26% | 33 | 0.36 | 9.25 | 2,245.57 ARS | +26.43% | 1.73% | — |
| ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 432.61 T ARS | 24,850 ARS | +1.43% | 1.73 K | 0.62 | 11.07 | 2,245.57 ARS | +58.44% | 1.73% | — |
 NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD)DR | 294.09 T ARS | 31.45 USD | +16.48% | 11 | 1.62 | 4.91 | 6,872.32 ARS | −11.51% | 3.63% | — |
| NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 294.09 T ARS | 39,200 ARS | +1.95% | 9 | 0.03 | 5.70 | 6,872.32 ARS | +10.89% | 3.63% | — |
 ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD)DR | 293.75 T ARS | 32.90 USD | −3.80% | 13 | 0.31 | 18.56 | 1,901.66 ARS | +327.44% | 0.90% | — |
| ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 293.75 T ARS | 42,925 ARS | +2.63% | 1.1 K | 2.87 | 22.57 | 1,901.66 ARS | +435.68% | 0.90% | — |
 AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)DR | 283.88 T ARS | 37.95 USD | +7.05% | 4 | 0.62 | 41.67 | 977.22 ARS | +96.72% | 1.50% | — |
| AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 283.88 T ARS | 46,550 ARS | +2.93% | 158 | 0.30 | 47.64 | 977.22 ARS | +146.53% | 1.50% | — |
 MRKCMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 268.67 T ARS | 16.65 USD | +5.71% | 33 | 0.00 | 13.41 | 1,332.07 ARS | +283.54% | 2.05% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 268.67 T ARS | 16.95 USD | −4.51% | 384 | 0.82 | 13.65 | 1,332.07 ARS | +283.54% | 2.05% | — |
| MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 268.67 T ARS | 21,750 ARS | +2.59% | 5.19 K | 0.99 | 16.33 | 1,332.07 ARS | +380.66% | 2.05% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 236.7 T ARS | 7,340 ARS | +1.52% | 190 | 1.10 | 99.20 | 73.99 ARS | +152.31% | 0.00% | — |
 TMODTHERMO FISHER SCIENTIFIC INC CEDEAR EAC 22 REP 1(USD)DR | 205.32 T ARS | 19.30 USD | +5.46% | 10 | 0.12 | 27.54 | 751.97 ARS | +90.57% | 0.21% | — |
| TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1 DR | 205.32 T ARS | 25,125 ARS | −0.30% | 463 | 0.21 | 33.41 | 751.97 ARS | +138.83% | 0.21% | — |
 AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD)DR | 204.24 T ARS | 9.90 USD | −0.60% | 99 | 0.80 | 29.88 | 355.48 ARS | +73.19% | 1.62% | — |
| AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 204.24 T ARS | 12,800 ARS | +1.99% | 837 | 0.34 | 36.01 | 355.48 ARS | +117.04% | 1.62% | — |
 PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)DR | 184.3 T ARS | 6.35 USD | −1.55% | 3.42 K | 1.51 | 20.01 | 340.44 ARS | +582.03% | 3.57% | — |
| PFECPFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05 DR | 184.3 T ARS | 6.39 USD | −0.78% | 11 | 0.30 | 20.14 | 340.44 ARS | +582.03% | 3.57% | — |
| PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 184.3 T ARS | 8,210 ARS | +0.49% | 15.65 K | 0.89 | 24.12 | 340.44 ARS | +754.74% | 3.57% | — |
 DHRDDANAHER CORP CEDEAR EACH 54 REPR 1 ORD UNSPON USDDR | 180.98 T ARS | 3.725 USD | +1.92% | 26 | — | 42.95 | 93.05 ARS | +50.37% | 0.40% | — |
| DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORD DR | 180.98 T ARS | 4,725 ARS | −1.66% | 661 | 0.36 | 50.78 | 93.05 ARS | +88.45% | 0.40% | — |
 GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD)DR | 178.3 T ARS | 27.20 USD | −4.90% | 14 | 0.48 | 25.35 | 1,151.42 ARS | — | 1.48% | — |
| GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 178.3 T ARS | 36,300 ARS | +4.39% | 533 | 0.75 | 31.53 | 1,151.42 ARS | — | 1.48% | — |
 VRTXVERTEX PHARMACEUTICAL CEDEAR EACH 101 REPR 1 ORDDR | 155.11 T ARS | 6,090 ARS | +2.87% | 414 | 0.79 | — | −245,320.18 ARS | −133.72% | 0.00% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 147.02 T ARS | 29,075 ARS | +1.48% | 82 | 0.35 | 32.39 | 897.57 ARS | +157.44% | 1.98% | — |
 BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USDDR | 123.2 T ARS | 15.95 USD | −1.54% | 3 | 0.02 | 19.74 | 866.77 ARS | — | 3.30% | — |
| BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 123.2 T ARS | 20,450 ARS | +2.89% | 806 | 0.79 | 23.59 | 866.77 ARS | — | 3.30% | — |
 GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)DR | 98.85 T ARS | 9.62 USD | −2.63% | 10 | 0.26 | 21.72 | 475.21 ARS | +32.57% | 3.11% | — |
| GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 98.85 T ARS | 12,400 ARS | +1.64% | 285 | 0.32 | 26.09 | 475.21 ARS | +66.14% | 3.11% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 29.41 T ARS | 6,260 ARS | +2.62% | 552 | 1.29 | — | −805.76 ARS | −134.47% | 4.12% | — |
 BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)DR | 24.94 T ARS | 10.35 USD | 0.00% | 852 | 10.81 | 15.04 | 738.48 ARS | +101.66% | 0.00% | — |
| BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 24.94 T ARS | 13,225 ARS | +0.38% | 2.41 K | 0.69 | 17.91 | 738.48 ARS | +152.73% | 0.00% | — |
 MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD)DR | 16.26 T ARS | 1.775 USD | −0.84% | 3.42 K | 0.82 | — | −424.06 ARS | −9.94% | 0.00% | — |
| MRNACMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 16.26 T ARS | 1.745 USD | +28.31% | 42 | — | — | −424.06 ARS | −9.94% | 0.00% | — |
| MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 16.26 T ARS | 2,225 ARS | −0.45% | 15.05 K | 0.32 | — | −424.06 ARS | −37.78% | 0.00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 113.46 B ARS | 1,405 ARS | −3.10% | 13.16 K | 1.29 | 5.67 | 247.77 ARS | — | 1.91% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 8.79 B ARS | 206.50 ARS | −11.37% | 868.87 K | 1.96 | — | −54.59 ARS | −355.19% | 0.00% | — |